Introduction {#s1}
============

Probiotics are live, non-pathogenic microorganisms consumed by target species, which may be humans, animals, or avian species ([@r013]). Among probiotics, lactic acid bacteria (LAB) are of particular interest to the food industry, since these bacteria have generally regarded as safe (GRAS) status (Altuntas, 2013). Through clinical, animal, and cellular experiments, researchers have shown that probiotic preparations consisting of dead cells and their metabolites can also be biological response modifiers ([@r022]). This paradox of probiotics has been concisely reviewed by [@r001] and Taverniti and Guglielmetti (2011), who reported probiotics as paraprobiotics or ghost probiotics. The impact of probiotics can be attributed to their molecular components, and their effects can be mediated by either live or dead cells. Nevertheless, scientific evidence implies that inactivated microbes and their metabolites positively affect human and animal health ([@r001]; [@r012]; [@r015]). Accordingly, products designed with heat-killed strain *Lactobacillus acidophilus* (*L. acidophilus*) from human origin *Lactéol* strain ([@r008]) have been imported and marketed in China since early 1998 (PUMC Pharmaceutical Co., Ltd). Thus, the therapeutic effects of genus *Lactobaccillus* are well known, and their actions against infections and bacterial pathogens in different types of food products are in high demand as well ([@r002]).

Currently, a few cultures have already been introduced to the market as starters or bio-protective cultures with the purpose of ensuring microbiological safety ([@r005]). For example, a mixed culture of *Pediococcus acidilactici* and *Lactobacillus curvatus* in Bactoferm F-Lc has been patented by Christian Hansen as an antilisterial culture in fermented sausages ([@r005]). Those cultures produce pediocin and sakacin A, respectively. *Lactobacillus sakei* B-2 and *Leuconostoc carnosum* (*Lc. carnosum*) 4010 (B-SF-43) are also used as bio-protective cultures for vacuum-packed and meat products (Aymerich *et al.*, 2008). Pathogenic spoilage bacteria such as *Listeria monocytogenes*, *Salmonella* species, *Escherichia coli* O157:H7, *Staphylococcus aureus*, *Leuconostoc mesenteroides*, *Lc. carnosum*, *Brochothrix thermosphacta*, and other pathogens were shown to be isolated from ready-to-eat meat products and suppressed using LAB ([@r005]). A couple of reports have shown that *Bifidobacterium breve*, *L. acidophilus*, and *Lactobacillus casei* (*L. casei*) reduce viability of the infection pathogen *Cronobacter sakazakii* (*C. sakazakii*), formerly *Enterobacter sakazakii*, which is present in commercially produced infant formula ([@r014]).

*Cronobacter* species have been detected as causative agents of infection in both adults and infants. It was reported that contamination levels of *C. sakazakii* are usually \<1.0 colony forming unit (CFU)/100 g in powdered infant formula, as determined by the most probable number method ([@r018]). Contamination incidence in international surveys has been shown to range from 2.4 to 14% ([@r014]; [@r020]), whereas United States Food and Drug Administration field surveys reported 6.6% incidence ([@r023]). The presence of *Cronobacter* in manufacturing plants is presumably due to post-processing, e.g., during dry-mixing of the finished product, filling, and packaging ([@r020]). It has been reported that control of *Cronobacter* species is very difficult in a processing environment due to the widespread nature of the organism. Common ingredients such as lactose, whey and soy protein concentrates, vegetable oil, vitamin and minerals, corn syrup, and corn maltodextrin are consumed as potential nutrients of *Cronobacter* species ([@r018]). Scientific investigation of the physiology of this pathogenic bacterium has confirmed the biofilm-forming ability and high resistance of *Cronobacter* species against antibacterial agents. There have been many reports on inactivation of *Cronobacter* species using trans-cinnamaldehyde ([@r003]), lactic acid, copper (II), monolaurin, and antimicrobial peptides such as caseicin A and caseicin B from *L. acidophilus* DPC 6026 ([@r003]; [@r011]). However, these natural compounds are not applicable for application in infant milk formula due to their strong flavors. Even though propionic acid and acetic acid have GRAS status, they are currently not included in Codex standards for infant formula ([@r016]).

The purpose of this research was to identify natural and safe bio-preservatives that are industrially operable and safe for infants. Fermented milk with *L. acidophilu*s n.v. Er2 317/402 strain Narine is a supplementary source of nutrition for newborns and used as an alternative to baby formula under the trade name Narine. Narine baby food has a time proven track record as a safe baby nutrition formulation ([@r019]). *L. acidophilus* n.v. Er2 317/402 strain Narine is known as a health beneficial functional probiotic culture. The strain Narine suppresses pathogenic microorganisms, as classified by the World Health Organization ([@r019]). Therefore, this study was performed to assess if Narine could be employed as a food preservative by inhibiting growth of *C. sakazakii*.

Materials and Methods {#s2}
=====================

Strains and materials {#s2a}
---------------------

Lyophilized *L. acidophilus* n.v. Er2 317/402 strain Narine (Narine-L) originally isolated from feces of newborn babies was purchased from Atlas R&D Inc. (Cambridge, Canada) in encapsulated form. To measure the viability of Narine cells, 100 mg of Narine-L was suspended in 50 mL of sterilized skim milk. After mixing very gently, the suspension was kept in a refrigerator at 4℃ for 24 h to revive bacterial cells. The suspension was mixed periodically with specific time intervals of 8-10 h. After 24 h, the entire 50 mL suspension was sent to Lab Services Division (Guelph, Canada) for colony counting. Enumeration of *L. acidophilus* n.v. Er2 317/402 strain Narine was carried out on an automated TEMPO system (bioMérieux, France).

*C. sakazakii* ATCC 29544 was purchased from the American Type Culture Collection (Rockville, USA) and used as an artificial contaminant microorganism. *C. sakazakii* was cultivated overnight in brain heart infusion (BHI) broth and on violet red bile glucose (VRBG) agar plates (MB Cell, USA). Yeast extract, peptone, L-cysteine, Tween-80, and skim milk were purchased from (Difco, USA). Glucose, phosphotungstic acid, and tetracycline were purchased from Sigma (USA).

Screening for antimicrobial activity {#s2b}
------------------------------------

To determine whether or not the antimicrobial activity of *L. acidophilus* n.v. Er2 317/402 strain Narine is due to its metabolites, cells were subjected to heat-kill treatment. Narine-L cells were heat-killed at 80℃ for 30 min and named Narine-heat treated (Narine-HT). Further, extracellular extracts were collected from Narine-HT by sequential extraction using water, sonication, and centrifugation; Narine-HT (2 g) was hydrated with 10 mL of sterile water, vortexed, and crushed in a Restch mill (Haan, Germany) for 1 min. Supernatant was obtained by high speed centrifugation at 11,000 *g* for 15 min at 4℃, followed by filtration through a 0.25 μm microfilter (Advantec, Japan) to remove bacterial cells. The resulting filtrates were lyophilized and designated as Narine crude cell-free extract (Narine-CCFE) for further evaluation.

The agar well diffusion method was used to measure the antimicrobial activities of Narine-L, Narine-HT, and Narine-CCFE against *C. sakazakii*. In brief, overnight culture of *C. sakazakii* (1 mL) was mixed with 100 mL of semi-solid BHI medium containing 0.7% agar, poured as a second layer, and allowed to solidify before cutting wells as previously described by Awaisheh *et al.* (2013). Each 30 mg of Narine-L, Narine-HT, and Narine-CCFE was applied to 5 mm wells and then incubated at 30℃ overnight. Inhibition zone around each well was measured and expressed in units (0.1 mm = 1 U). The diameter of the halo was deducted from the diameter of the well (15 mm = 150 U). Tetracycline (0.01 μg/mL) was used as a positive control. The test was performed in triplicate and repeated twice.

Elimination of *C. sakazakii* by Narine-L and Narine-HT in infant formula model {#s2c}
-------------------------------------------------------------------------------

Ten grams of commercial infant powdered milk (Maeil Dairy Industry Co., Korea) was mixed with 90 mL of sterile distilled water under aseptic conditions to make reconstituted powdered infant formula (RPIF). Then, 100 μL of *C. sakazakii* (10^8^ CFU/mL) was subjected to 10 mL of RPIF with 1 g each of Narine-L and Narine-HT. A negative control was prepared without both Narine-L and Narine-HT. In a subsequent experiment, samples (1 mL) were aseptically collected every 0, 3, and 6 h of incubation at 37℃ and serially diluted in 0.1% peptone water for enumeration of *C. sakazakii*. From the appropriate dilution, 100 μL of each sample was spread onto the surface of a VRBG agar plate to determine the number of viable *C. sakazakii*.

Transmission electron microscopy (TEM) {#s2d}
--------------------------------------

To observe the morphology of *C. sakazakii* cells after treatment with Narine-CCFE, *C. sakazakii* cells were subjected to TEM according to the method recommended by Coconnier *et al.* (1997). After negative staining with 2% phosphotungstic acid (w/v), cell morphology was examined using TEM (H-7600; Hitachi, Japan) at 80 kV.

Results and Discussion {#s3}
======================

Antimicrobial activity of Narine by agar well diffusion method {#s3a}
--------------------------------------------------------------

The antimicrobial activity of Narine against *C. sakazakii* (10^8^ CFU/mL) was expressed as the diameter (U) of the inhibition zone around Narine-L, Narine-HT, and Narine-CCFE. The zone ranged from 150 to 200 U ([Fig. 1](#f001){ref-type="fig"}). The same amounts (30 mg) of Narine-L, Narine-HT, and Narine-CCFE were tested against *C. sakazakii*, and the highest inhibitory activities (200 U) were observed with Narine-CCFE, which is a soluble caramelized material. The component(s) in Narine-CCFE providing antimicrobial activity was acidic or required an acidic environment to ideally develop antimicrobial activities. Treated Narine-CCFE with phosphate buffer at neutral pH did not exhibit any antimicrobial activity (data not shown). In recent studies, it was demonstrated that a mixture of caprylic acid, citric acid, and vanillin had a destructive effect on a number of *Cronobacter* strains ([@r007]). The authors specified that there was significant synergistic activity of the antimicrobials against the pathogens ([@r007]). In this respect, it seems that the acid components in Narine-CCFE are potent antimicrobials, possibly due to the greater proportion of acid molecules in undissociated form, which rapidly enter *Cronobacter* cells and increase levels of cytoplasmic acidification in bacteria.

![Antimicrobial activity of Narine-lyophilized, Narine-heat treated, and Narine crude cell-free extract.](kosfa-36-635-f001){#f001}

Inactivation of *C. sakazakii* in infant formula model using Narine-L and Narine-HT {#s3b}
-----------------------------------------------------------------------------------

Furthermore, Narine-L and Narine-HT were used in an infant formula model to reduce 1.62×10^8^-5.36×10^9^ CFU/mL after 3 and 6 h ([Table 1](#t001){ref-type="table"}). The result of enumeration for *C. sakazakii* were counted on VRBG agar plate before and after treatment with Narine-L and Narine-HT, respectively. After treatment with Narine-L and Narine-HT for 3 h and 6 h at 37℃, less than ≤ 10^7^ CFU/mL of *C. sakazakii* were detected in RPIF. On the other hand, without treatment of Narine-L and Narine-HT, the population of *C. sakazakii* increased up to 5.36×10^9^ after 6 h.

###### Average number of *Cronobacter sakazakii* cells under treatment with Narine in powdered infant formula (Unit: CFU/mL)

  Sample                     0 h          3 h          6 h
  -------------------------- ------------ ------------ ------------
  Control ^a)^               1.62×10^8^   3.17×10^9^   5.36×10^9^
  Narine-lyophilized^b)^     1.62×10^8^   ≤10^7^       ≤10^7^
  Narine-heat treated ^c)^   1.62×10^8^   ≤10^7^       ≤10^7^

^a)^Reconstituted powdered infant formula artificially contaminated with *Cronobacter sakazakii*. ^b)^Reconstituted powdered infant formula artificially contaminated with *Cronobacter sakazakii* under treatment with Narine-lyophilized. ^c)^Reconstituted powdered infant formula artificially contaminated with *Cronobacter sakazakii* under treatment with Narine-heat treated.

TEM analysis {#s3c}
------------

To further characterize the antimicrobial effect of Narine-CCFE, we used TEM ([@r009]) to examine *C. sakazakii* cells before and after treatment with Narine-CCFE ([Fig. 2](#f002){ref-type="fig"}). Zoomed micrograph shows live cells of *C. sakazakii*, which are transparent ([Fig. 2A](#f002){ref-type="fig"}), whereas after less than 3 h of treatment with 30 mg of Narine-CCFE, there are detectable examples of altered cell membrane morphology ([Fig. 2B](#f002){ref-type="fig"}). A similar observation was made for the spent culture supernatant of human *L. acidophilus* strain LB (LB-spent culture supernatant), producing antimicrobial activity against a wide range of gram-negative and gram-positive pathogens ([@r006]; [@r008]). The TEM images corroborate the previous studies performed by [@r008], where TEM images showed a damaged cell membrane morphology. Close examination of both images, *Salmonella* Typhimurium SL 1344 treated with LB-spent culture supernatant and our *C. sakazakii* treated with Narine-CCFE, showed the same altered cell envelope. [@r010] reported that inactivated bacterial cells showed a less defined envelope along with a rugged cell wall, suggesting that inactivated cells appeared due to reduced integrity of the cell envelope and aggregation of cytoplasmic components.

![Transmission electron microscopy of *Cronobacter sakazakii*.](kosfa-36-635-f002){#f002}

In a previous work, *L. acidophilus* n.v. Er2 317/402 strain Narine, grown on chemically-defined synthetic medium, was reported to have pathogen-killing effects due to acidocin LCHV ([@r019]). However, we were unable to detect the same acidocin LCHV when Narine was grown in industrially available skim milk (data not shown). Nevertheless, we provide evidence that this inhibition occurred when the pH of Narine-CCFE was acidic while no growth inhibition occurred when the pH of Narine-CCFE was neutral. Our findings are in agreement with those reported by [@r021], who showed that antimicrobial activity resulted from an acidic pH, which functions as a permeabilizer of the outer membrane of gram-negative bacteria and may potentiate the effects of other antimicrobial substances.

A few studies investigated the direct inhibitory effect of *Lactobacillus* on *Cronobacter*. One study demonstrated the beneficial effects of human strains of *L. casei* and *L. acidophilus* against *C. sakazakii* ([@r004]). Initially, LAB strains were isolated from infant stool samples and screened to show bacteriocin production by using cell-free supernatant against *C. sakazakii* in RPIF. The results showed that *L. casei* and *L. acidophilus* reduced *C. sakazakii* ([@r004]). In a present work, human strain *L. acidophilus* n.v. Er2 317/402 Narine and its metabolites inhibited *C. sakazakii*. With regard to *Cronobacter*, [@r017] found that strains *Lactobacillus kefiri* and *Candida kefyr* either individually or in combination with their supernatants significantly reduced growth of *Cronobacter* strains in RPIF. However, it is known that kefir grains are a combination of LAB, acetic acid bacteria, and yeast, whereas *L. acidophilus* n.v. Er2 317/402 Narine is a pure culture isolated from newborn baby feces and is already used in baby food.

Conclusions {#s4}
===========

This preliminary study demonstrated the antimicrobial activity of *L. acidophilus* n.v. Er2 317/402 strain Narine against *C. sakazakii* in vitro. Narine-L, Narine-HT, and Narine-CCFE of 30 mg showed inhibition zones from 150 to 200 U, with the largest inhibition (200 U) induced by Narine-CCFE. One gram each of Narine-L and Narine-HT was added to 10 mL of artificially contaminated RPIF containing 100 μL of *C. sakazakii* (1.62×10^8^ CFU/mL), and the results showed that Narine-L and Narine-HT inhibited 1.62×10^8^-5.36×10^9^ CFU/mL of *C. sakazakii* throughout 6 h at 37℃. TEM analysis confirmed the susceptibility of *C. sakazakii* by *L. acidophilus* n.v. Er2 317/402 Narine. The administration of Narine strains in infant milk formula might promote safety of infant foods. Further studies are needed to investigate the metabolite components responsible for antimicrobial activity.
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